Time-points for minimal residual disease monitoring in patients with acute myeloid leukemia who underwent allogeneic stem cells transplantation: a comparison between multiparameter flow cytometry and Wilm's tumor 1 expression

被引：0
|
作者：
Rossi, G. [1 ]
Carella, A. M. [1 ]
Minervini, M. M. [1 ]
di Nardo, F. [2 ]
Greco, M. M. [1 ]
Meria, E. [1 ]
Savino, L. [1 ]
de Gills, G. P. [1 ]
Di Renzo, N. [3 ]
Melpignano, A. [4 ]
Capalbo, S. [5 ]
Pisapia, G. [6 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, Dept Hematol, San Giovanni Rotondo, Italy
[2] Univ Cattolica Sacro Cuore, Dept Hyg, I-00168 Rome, Italy
[3] Vito Fazzi Hosp, Dept Hematol, Lecce, Italy
[4] Perrino Hosp, Dept Hematol, Brindisi, Italy
[5] Riuniti Hosp, Dept Hematol, Foggia, Italy
[6] San Giuseppe Moscati Hosp, Dept Hematol, Taranto, Italy
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P244
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [31] The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation
    Wang, Ziwei
    Guo, Mengqiao
    Zhang, Yuesheng
    Xu, Sheng
    Cheng, Hui
    Wu, Jiawei
    Zhang, Weiping
    Hu, Xiaoxia
    Yang, Jianmin
    Wang, Jianmin
    Tang, Gusheng
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) : 607 - 614
  • [32] Evaluation of 272 patients with chronic myeloid leukemia who underwent allogeneic stem cells transplantation between 1998 and 2007
    Hamladji, R. -M.
    Benakli, M.
    Nacer, R. Ahmed
    Harieche, F.
    Talbi, A.
    Belhadj, R.
    Mehdid, F.
    Rahmoune, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S493 - S493
  • [33] LEUKEMIA ASSOCIATED EXPRESSION PATTERNS OF DIFFERENTIATION ANTIGENS IN ACUTE LYMPHOBLASTIC-LEUKEMIA FOR MONITORING OF MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW-CYTOMETRY
    GRIESINGER, F
    FALK, M
    PIRONOACK, M
    RITTER, J
    BUCHNER, T
    HIDDEMANN, W
    TERSTAPPEN, LWMM
    WORMANN, B
    BLOOD, 1994, 84 (10) : A300 - A300
  • [34] Comparison of the Performance of Multiparameter Flow-Cytometry and wt1-RNA Levels in Detecting Minimal Residual Disease and Predicting Relapse in Patients with Acute Myeloid Leukemia
    Rossi, Giovanni
    Minervini, Mariella
    Carella, Angelo Michele
    de Waure, Chiara
    Melillo, Lorella
    D'Arena, Giovanni Francesco
    Cascavilla, Nicola
    Zini, Gina
    BLOOD, 2011, 118 (21) : 1073 - 1073
  • [35] Early assessment of minimal residual disease by multiparameter flow cytometry identifies patients at high risk of relapse after allogeneic stem cell transplantation following reduced intensity conditioning for advanced acute myeloid leukemia.
    Kern, W
    Voskova, D
    Schnittger, S
    Schoch, C
    Schmid, C
    Hiddemann, W
    Kolb, HJ
    Haferlach, T
    BLOOD, 2003, 102 (11) : 481A - 482A
  • [36] Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms' Tumor I Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism
    Kwon, Mi
    Martinez-Laperche, Carolina
    Infante, Maria
    Carretero, Fernando
    Balsalobre, Pascual
    Serrano, David
    Gayoso, Jorge
    Perez-Corral, Ana
    Anguita, Javier
    Luis Diez-Martin, Jose
    Buno, Ismael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1235 - 1242
  • [37] Combination of Minimal Residual Disease By Flow Cytometry before and after Hematopoietic Stem Cell Transplantation Predicts Survival in Patients with Acute Myeloid Leukemia
    Nunez-Torron, Claudia
    Jimenez, Carlos
    Moro, Fernando Martin
    Marquet, Juan
    Piris-Villaespesa, Miguel
    Hernandez, Clara Lopez
    Luna, Alejandro
    Gutierrez Sr, Valentin Garcia
    Chinea, Anabelle
    Jimenez, Maria Gemma Moreno
    Lopez, Javier
    Puente, Pilar Herrera
    BLOOD, 2024, 144 : 7445 - 7446
  • [38] Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Perez-Lopez, Olga
    Caballero-Velazquez, Teresa
    Colado, Enrique
    Alonso, Sara
    Gonzalez-Campos, Jose
    Prats-Martin, Concepcion
    Rodriguez-Torres, Nancy
    Escamilla Gomez, Virginia
    Espigado, Ildefonso
    Antonio Perez-Simon, Jose
    BLOOD, 2018, 132
  • [39] Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia
    Shimomura, Yoshimitsu
    Maruoka, Hayato
    Yabushita, Tomohiro
    Hashimoto, Hisako
    Ishikawa, Takayuki
    BLOOD, 2017, 130
  • [40] Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Martin-Rojas, Reyes Maria
    Oarbeascoa, Gillen
    Bailen, Rebeca
    Gomez-Centurion, Ignacio
    Juarez, Luis Miguel
    Dorado, Nieves
    Martinez-Laperche, Carolina
    Perez-Corral, Ana
    Buno, Ismael
    Anguita, Javier
    Diez-Martin, Jose L.
    Kwon, Mi
    BLOOD, 2020, 136
12345